Yıl: 2018 Cilt: 7 Sayı: 3 Sayfa Aralığı: 532 - 535 Metin Dili: İngilizce DOI: 10.5455/medscience.2018.07.8813 İndeks Tarihi: 19-09-2019

Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection

Öz:
Increased urine albumin excretion is suggested to be an early marker of glomerular damage. Evaluation of a test’s performance characteristics such as diagnostic sensitivity and specifictiy is a necessity before application into routine practice. To our knowledge up to now there is no study evaluating Dirui test strips for albuminuria determination. Therefore the objective of this study was to test these strips for agreement with the established method used in our routine laboratory. Freshly collected 177 urine specimens were included in the study. Strips were read on instruments Dirui H-500 and Dirui H-800 using reflectance photometry. For DiruiH13-Cr strip albumin to creatinine ratio (ACR) and for DiruiH12-800MA strip albumin determinations were compared with the analyses performed using immunoturbidimetry and kinetic Jaffe method. Sensitivity values for estimated ACR using DiruiH13-Cr strip and albumin concentration using DiruiH12-800MA strip were calculated as 80%, 72%, respectively. Specificity values were as; 71% for Dirui H13-Cr strip and 78% for Dirui H12-800MA strip. Screening tests using urine test strips should be validated before acceptance in the routine use. Dirui strips evaluated in this study seem to have a lower sensitivity than suggested and excess number of false negatives seems to limit utility of these strips.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1-150.
  • American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care. 2013;36:11-66.
  • Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 200113;414:782-7.
  • Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7:35-43.
  • Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110:32-5.
  • Miller WG, Bruns DE, Hortin GL, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem. 2009;55:24-38.
  • Lippi G, Becan-McBride K, Behulova D, et al. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med. 2013;51:229-41.
  • National Kidney Foundation. Kidney disease outcomes quality inıtiative. clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Diseases. 2007;49:42-61.
  • Wong HB LG. Measures of diagnostic accuracy: Sensitivity, specificity, PPV and NPV. Proceedings of Singapore Healthcare. 2011;20:316-8.
  • Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ. 1994 ;308:1552.
  • J Am Soc Nephrol. 2003/06/24 edition 2003. Prevalence of kidney damage in Australian adults: The AusDiab kidney study; p. S131-8.
  • Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-47.
  • Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275-84.
  • Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51:373-84.
  • Lamb EJ, Levey AS, Stevens PE. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin Chem. 2013;59:462-5.
  • National Institute for Health and Care Excellence. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. NICE clinical guideline 73. Manchester, United Kingdom. National Institute for Health and Care Excellence. 2008.
  • National Institute for Health and Care Excellence. Type 1 diabetes: diagnosisand management of type 1 diabetes in children, young people and adults. NICE clinical guideline
  • National Institute for Health and Care Excellence. Type 2 diabetes. NICE clinical guideline 66. Manchester, United Kingdom: National Institute for Health and Care Excellence. 2009.
  • Sacks DB, Arnold M, Bakris GL, et al. Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57:793-8.
  • McTaggart MP, Newall RG, Hirst JA, et al. Diagnostic accuracy of point-ofcare tests for detecting albuminuria: a systematic review and meta-analysis. Ann Intern Med. 2014;160:550-7.
  • Howey JE, Browning MC, Fraser CG. Biologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs. Am J Kidney Dis. 1989;13:35-7.
  • Decavele AS, Fiers T, Penders J, et al. A sensitive quantitative test strip based point-of-care albuminuria screening assay. Clin Chem Lab Med. 2012;50:673-8.
  • Davidson MB, Bazargan M, Bakris G, et al. ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol. 2004;24:284-8.
  • Wilde HM, Banks D, Larsen CL, et al Evaluation of the Bayer microalbumin/ creatinine urinalysis dipstick. Clin Chim Acta. 2008;393:110-3.
  • Graziani MS, Gambaro G, Mantovani L, et al. Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. Nephrol Dial Transplant. 2009;24:1490-4.
  • Mattix HJ, Hsu CY, Shaykevich S, et al. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002;13:1034-9.
  • Jacobs JD, Murtaugh MA, Steffes M, et al. Gender- and Race-specific Determination of Albumin Excretion Rate usingAlbumin-to-Creatinine Ratio in Single, Untimed Urine Specimens. Am J Epidemiol. 2002;155:1114-9.
  • Ellam TJ. Albumin:creatinine ratio--a flawed measure? The merits of estimated albuminuria reporting. Nephron Clin Pract. 2011;118:c324-30.
APA AKBULUT E, ERCAN KARADAĞ M, Yılmaz F (2018). Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. , 532 - 535. 10.5455/medscience.2018.07.8813
Chicago AKBULUT Emiş Deniz,ERCAN KARADAĞ MÜJGAN,Yılmaz Fatma Meriç Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. (2018): 532 - 535. 10.5455/medscience.2018.07.8813
MLA AKBULUT Emiş Deniz,ERCAN KARADAĞ MÜJGAN,Yılmaz Fatma Meriç Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. , 2018, ss.532 - 535. 10.5455/medscience.2018.07.8813
AMA AKBULUT E,ERCAN KARADAĞ M,Yılmaz F Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. . 2018; 532 - 535. 10.5455/medscience.2018.07.8813
Vancouver AKBULUT E,ERCAN KARADAĞ M,Yılmaz F Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. . 2018; 532 - 535. 10.5455/medscience.2018.07.8813
IEEE AKBULUT E,ERCAN KARADAĞ M,Yılmaz F "Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection." , ss.532 - 535, 2018. 10.5455/medscience.2018.07.8813
ISNAD AKBULUT, Emiş Deniz vd. "Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection". (2018), 532-535. https://doi.org/10.5455/medscience.2018.07.8813
APA AKBULUT E, ERCAN KARADAĞ M, Yılmaz F (2018). Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. Medicine Science, 7(3), 532 - 535. 10.5455/medscience.2018.07.8813
Chicago AKBULUT Emiş Deniz,ERCAN KARADAĞ MÜJGAN,Yılmaz Fatma Meriç Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. Medicine Science 7, no.3 (2018): 532 - 535. 10.5455/medscience.2018.07.8813
MLA AKBULUT Emiş Deniz,ERCAN KARADAĞ MÜJGAN,Yılmaz Fatma Meriç Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. Medicine Science, vol.7, no.3, 2018, ss.532 - 535. 10.5455/medscience.2018.07.8813
AMA AKBULUT E,ERCAN KARADAĞ M,Yılmaz F Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. Medicine Science. 2018; 7(3): 532 - 535. 10.5455/medscience.2018.07.8813
Vancouver AKBULUT E,ERCAN KARADAĞ M,Yılmaz F Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. Medicine Science. 2018; 7(3): 532 - 535. 10.5455/medscience.2018.07.8813
IEEE AKBULUT E,ERCAN KARADAĞ M,Yılmaz F "Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection." Medicine Science, 7, ss.532 - 535, 2018. 10.5455/medscience.2018.07.8813
ISNAD AKBULUT, Emiş Deniz vd. "Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection". Medicine Science 7/3 (2018), 532-535. https://doi.org/10.5455/medscience.2018.07.8813